GOLDMAN SACHS GROUP INC - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 48 filers reported holding AYTU BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q1 2022$54,000
-1.8%
50,146
+22.7%
0.00%
Q4 2021$55,000
-60.7%
40,867
-15.9%
0.00%
Q3 2021$140,000
+97.2%
48,593
+244.2%
0.00%
Q2 2021$71,000
-88.0%
14,118
-81.9%
0.00%
Q1 2021$592,00077,9580.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 362,910$2,758,0001.49%
ARMISTICE CAPITAL, LLC 1,342,378$10,202,0000.23%
OCCUDO QUANTITATIVE STRATEGIES LP 60,112$457,0000.10%
Pinz Capital Management, LP 18,000$137,0000.04%
WINTON GROUP Ltd 46,649$355,0000.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 10,880$83,0000.02%
Allred Capital Management, LLC 2,719$20,664,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 41,007$312,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 21,161$161,0000.00%
Sigma Planning Corp 10,722$81,0000.00%
View complete list of AYTU BIOPHARMA INC shareholders